Editorial
Journal Title: Üroonkoloji Bülteni - Year 2017, Vol 16, Issue 4
Abstract
.
Authors and Affiliations
Murat Koşan
Keywords
Related Articles
- EP ID EP369500
- DOI -
- Views 83
- Downloads 0
Transurethral Resection of the Bladder Tumor Success Rates of Surgeons and Possible Causes of Differences Between Locals and Refugees
Objective: In our study, we examined the success rates of our surgeons and the criteria that define the success, and tried to reveal the possible causes of the differences in the success rates of transurethral resection...
The Effect of Tumor Size on Oncologic Outcomes in Pathological T2 Stage Renal Cell Carcinoma Patients
Objective: To evaluate the oncologic outcomes in T2 stage renal cell carcinoma (RCC) patients who underwent open radical nephrectomy and the effect of patient’s tumor size on the oncologic outcomes. Materials and Methods...
Risk Factors for Adrenal Invasion in Renal Cell Carcinoma
Objective: In this study, we aimed to describe the risk factors associated with adrenal invasion in patients who were diagnosed with renal cell carcinoma (RCC) after radical nephrectomy and identify which risk factors ar...
What are the New Developments in Urinary, Serum and Tissue Biomarkers in Prostate Cancer?
Currently the accepted screening tools for prostate cancer are prostate specific antigen (PSA) and rectal examination. PSA is specific to prostate, but not to prostate cancer. Therefore, identifying prostate cancer only...
Effects and Mechanisms of Checkpoint Inhibitors (CTLA-4, PD-1 and PD-L1 Inhibitors) as New Immunotherapeutic Agents for Bladder Cancer
Since intravesical Bacillus Calmette-Guerin (BCG) began to be used for bladder cancer, our understanding of the importance of immune mechanisms in bladder cancer has steadily grown. With developments in immunotherapy in...